Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism L-lactate dehydrogenase stimulants(L-lactate dehydrogenase stimulants) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC20H26ClNO3 |
InChIKeyPLSMXIQMWYSHIV-UHFFFAOYSA-N |
CAS Registry82168-26-1 |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | Adafenoxate | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cognition Disorders | Phase 3 | ES | - | - |
Cognition Disorders | Phase 3 | - | - | |
Parkinson Disease | Phase 3 | ES | - | - |